DiRaimondo Thomas
Chief Scientific Officer at JANX
- Sold, on record
- $266k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Jan 2, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- JANXJanux Therapeutics, Inc.Chief Scientific Officer
Sales by reason
0
Routine
0
Plan not stated
1
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice JANXNoticeSep 27, 2024 2024
Filed to sell 5,000 shares ($233k)
DiRaimondo Thomas, Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale JANXRoutineSep 27, 2024 same day
Sold 5,000 shares at $46.35 ($232k)
DiRaimondo Thomas, Chief Scientific Officer
10b5-1 planSold 4.9% of holdings ($4.8M position)97,938 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 4 sale JANXNo planJan 2, 2026 +462 days
Sold 2,505 shares at $13.73 ($34k)
DiRaimondo Thomas, Chief Scientific Officer
No 10b5-1 planSold 2% of holdings ($1.7M position)124,425 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Jan 2, 2026 | JANX | Chief Scientific Officer | Form 4 sale | 2,505 | $34k | 2.0% | No plan | SEC |
| Sep 27, 2024 | Sep 27, 2024 | JANX | Chief Scientific Officer | Form 4 sale | 5,000 | $232k | 4.9% | Routine | SEC |
| Sep 27, 2024 | Sep 27, 2024 | JANX | Officer | Form 144 notice | 5,000 | $233k | Notice | SEC |